Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bredius, Robbert G M  [Clear All Filters]
2024
Oostenbrink LVE, von Asmuth EGJ, van der Zijde CMJol-, Jansen-Hoogendijk AM, Vervat C, Bredius RGM, van Tol MJD, Schilham MW, Sedlacek P, Ifversen M, et al. Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study. Haematologica. 2024.
2022
Achini-Gutzwiller FR, van der Zijde CMJol-, Jansen-Hoogendijk AM, Lankester AC, Bredius RGM, van Tol MJD, Moes DJan AR, Schilham MW. Development and Validation of an Efficient and Highly Sensitive ELISA for Alemtuzumab Quantification in Human Serum and Plasma. Ther Drug Monit. 2022.
Admiraal R, Nierkens S, Bierings MB, Bredius RGM, van Vliet I, Jiang Y, Lopez-Yurda M, A Versluijs B, C Zwaan M, Lindemans CA, et al. Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial. Lancet Haematol. 2022;9(2):e111-e120.
2021
van der Stoep MYEileen C, Bertaina A, Moes DJan AR, Algeri M, Bredius RGM, Smiers FJW, Berghuis D, Buddingh EP, Mohseny AB, Guchelaar H-J, et al. Impact of treosulfan exposure on early and long-term clinical outcome in pediatric allogeneic HSCT recipients: a prospective multicenter study. Transplant Cell Ther. 2021.
2020
Lum SHan, Elfeky R, Achini FR, Margarit-Soler A, Cinicola B, Perez-Heras I, Nademi Z, Flood T, Cheetham T, Worth A, et al. Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency. J Clin Immunol. 2020.
2019
Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, et al. Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment During Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019.
Ferrua F, Galimberti S, Courteille V, Slatter MAnne, Booth C, Moshous D, Neven B, Blanche S, Laberko A, Shcherbina A, et al. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. J Allergy Clin Immunol. 2019.
2015
Admiraal R, van Kesteren C, van der Zijde CMJol-, Lankester AC, Bierings MB, Egberts TCG, van Tol MJD, Knibbe CAJ, Bredius RGM, Boelens JJ. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015;2(5):e194-203.
Wiekmeijer A-S, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero ILM, Lankester AC, Bredius RGM, van Dongen JJM, Fibbe WE, Langerak AW, et al. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol. 2015.
de Pagter APJ, Bredius RGM, Kuijpers TW, Tramper J, van der Burg M, van Montfrans J, Driessen GJ. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening. Eur J Pediatr. 2015.
Verhoeven DHJ, Claas ECJ, van der Zijde CMJol-, Thijssen JCP, Lankester AC, Bredius RGM, Putter H, Kroes ACM, R Egeler M, Schilham MW, et al. Reactivation of Human Herpes Virus-6 after Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association with Severity of Acute Graft-Versus-Host Disease. Pediatr Infect Dis J. 2015.
2014
Lugthart G, Oomen MA, van der Zijde CMJol-, Ball LM, Bresters D, Kollen WJW, Smiers FJ, Vermont CL, Bredius RGM, Schilham MW, et al. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution. Biol Blood Marrow Transplant. 2014.
Willemsen L, van der Zijde CMJol-, Admiraal R, Putter H, Jansen-Hoogendijk AM, Dam MMOstaijen, Wijnen JT, van Kesteren C, Waaijer JLM, Lankester AC, et al. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab. Biol Blood Marrow Transplant. 2014.
Wiekmeijer A-S, Pike-Overzet K, Brugman MH, Salvatori DCF, R Egeler M, Bredius RGM, Fibbe WE, Staal FJT. Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice. Biores Open Access. 2014;3(3):110-6.